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Abstract
Background: Atopic diseases, such as atopic dermatitis, allergic rhinitis, and asthma, are inflammatory diseases
common in pediatric patients. This study investigated whether these inflammatory atopic diseases were associated
with anemia in pediatrics.
Methods: A cross-sectional study was conducted using a pediatric dataset from the Health Insurance Review and
Assessment Service (HIRA) of South Korea in 2016. Multivariable logistic regression, adjusting for demographic
covariates was used for analyse the association between atopic disease and iron deficiency anemia (IDA).
Results: A total of 846,718 pediatric patients were included in the study. Of these, 19,594 (2.31%) had a diagnosis of
IDA. The logistic regression analyses including covariates revealed there were association between atopic disease
and IDA. The adjusted OR (aOR) of IDA was 1.42 (95% CI, 1.37–1.47) for atopic dermatitis, 1.25 (95% CI, 1.21–1.29) for
allergic rhinitis, and 1.71 (95% CI, 1.65–1.76) for asthma. IDA was more prevalent in patients with multiple comorbid
atopic diseases, with aOR of 1.30 (95% CI, 1.25–1.35), 1.81 (95% CI, 1.73–1.89), and 2.58 (95% CI, 2.43–2.73) for 1, 2, or
3 atopic diagnoses. There was no evidence of multicollinearity among covariates.
Conclusions: Our findings suggest that atopic disease was associated with IDA. Further study is needed to clarify
the distinction between IDA and/or AI to better understand the cause of anemia in patients with inflammatory
diseases.
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Background
Atopic diseases, such as atopic dermatitis, allergic rhinitis,
and asthma, are inflammatory diseases common in
pediatrics [1, 2]. Atopic diseases are often comorbid with
other diseases; indeed, the prevalence of infectious disease,
autoimmune disease, and mental illness is higher in these
patients than those without atopic disease [3–5], and these
conditions, singly or in combination, can decrease patients’
quality of life and increase morbidity and mortality [6–8].
No study has definitively evaluated whether the per-
sistent inflammatory state of atopic disease impacts the
risk of developing anemia. Although one study reported
an association between higher iron levels and a lower
prevalence of asthma [9], the design was cross-sectional,
making cause and effect difficult to discern. Another
study showed that the prevalence of anemia in children
with atopic disease is higher than in those without atopic
disease [10], but these findings relied on caregiver ques-
tionnaires, and the effects of other diseases or drugs that
simultaneously affect anemia and atopic disease were
not partitioned.
Therefore, in this study, we investigated whether the
chronic inflammatory state of atopic patients affects
their risk for anemia while controlling for potentially
confounding covariates. We considered the risk factors
for both atopic disease and anemia.
Methods
Study population
South Korea has a universal health insurance system,
into which approximately 98% of all citizens are en-
rolled. We used a dataset, Health Insurance Review and
Assessment Service - Pediatric Patient Sample, (HIRA-
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PPS-2016), that randomly stratified 10% of the pediatric
patients (~ 1,100,000) under 20 years of age who used a
medical institution during the year 2016 [11]. HIRA re-
ported that almost 90% of Koreans visit medical institu-
tions at least once a year [11]. In South Korea, health
care providers report diagnostic codes when prescribing
a medication or procedure, and patients are required to
physically visit their physician to receive prescriptions.
Thus, the requirement of diagnostic codes and absence
of refill and telemedicine models results in a dataset with
no missing diagnostic codes in the claim data.
The inclusion criterion in this study was patient age
under 18 years. Exclusion criteria for this study were: 1)
patients who were diagnosed with an anemia other than
IDA, 2) patients who were diagnosed with two or more
types of anemia. We chose IDA to evaluate if inflamma-
tion of atopic diseases increases the prevalence of
anemia since the hematologic characteristics of IDA is
similar with anemia of inflammation (AI). In addition,
other types of anemia except IDA, such as hemolytic
anemia, aplastic anemia or folate deficiency anemia,
were excluded in this study because of their low preva-
lence and different mechanisms of etiology. Diagnosis of
AI was very low prevalence in children and used for pa-
tients with specific chronic condition such as CKD or
cancer, so it was also excluded in this study.
Definition of diseases
We included atopic dermatitis, allergic rhinitis, and
asthma as atopic disease based on the presence of the
diagnostic code corresponding to one or more of these
diseases. Diagnostic codes for these diseases and covari-
ate diseases (see below) are based on The Korean Stand-
ard Classification of Disease and Cause of Death-7
(KCD-7) was used for definition of disease (Add-
itional file 1: Table S1). The KCD-7 reflects the update
of the International Classification of Diseases 10th Revi-
sion (ICD-10) and refines the Korean subtypes of disease
and rare diseases.
Covariates
Covariates were selected based on patient characteristics
and common risk factors for anemia and atopic disease.
Patient characteristics (age, sex, and insurance type),
medical conditions, and medication were included in
our analyses as covariates. We included systemic infec-
tion, chronic kidney disease (CKD), mental disorder,
chronic inflammation, and cancer as covariates for med-
ical condition. Systemic steroids, cyclosporine, and
methotrexate were included as covariates for medica-
tions. Specific diseases and corresponding KCD-7 codes
are listed in Additional file 1: Table S1.
Statistical analysis
We estimated crude odds ratio (cOR) and adjusted odds
ratio (aOR) with 95% confidence interval (CI). We uti-
lized stepwise multivariate binary logistic regression ana-
lysis, including the covariates described above.
Multicollinearity test were performed since we included
quite a few variables as covariates. All statistical analyses
were performed in SAS 9.4 (SAS Institute Inc., Cary,
NC, USA), and results were considered statistically sig-
nificant if the P-value was less than 0.05.
Results
Out of 1,004,866 patients included in the HIRA-PPS-
2016, 148,459 patients were older than 18, 9551 were di-
agnosed with anemia other than IDA, and 138 were had
more than one type of anemia diagnosis including IDA.
Therefore, we included 846,718 pediatric patients (Fig. 1).
The prevalence of all anemia was 3.46% (29,283 patients)
in the subjects. The IDA group comprised 2.31% (19,594
patients). The OR of IDA was higher in patients younger
[cOR = 0.89 (95% CI, 0.89–0.89); P < 0.001)], if age is as
continuous variable, in female patients [cOR = 1.20 (95%
CI, 1.17–1.24) relative to male patients; P < 0.001)], and
in Medical aid patients [cOR = 1.20 (95% CI, 1.04–1.23;
P = 0.006) relative to patients under health insurance
program. All covariates, including systemic infection,
mental disorder, CKD, chronic inflammation, cancer,
and medication (steroid, methotrexate, and cyclosporine)
indicated significantly higher ORs of IDA (Table 1).
Association of atopic disease and anemia
We found that the aOR of IDA was significantly higher
across patients with atopic disease, at 1.42 (95% CI,
1.37–1.47; P < 0.001), 1.25 (95% CI, 1.21–1.29; P <
0.001), and 1.71 (95% CI, 1.65–1.76; P < 0.001) in pa-
tients with atopic dermatitis, allergic rhinitis, and
asthma, respectively. All three atopic diseases demon-
strated a significant, positive association with IDA before
and after applying covariates (Table 2).
Multiple atopic diseases in a single patient had higher
associations with IDA than a single diagnosis. The aOR
for 1 atopic disease and IDA was 1.30 (95% CI, 1.25–
1.35; P < 0.001), increased to 1.81 (95% CI, 1.73–1.89);
P < .001) in those with 2 atopic diseases, and was highest
in patients with 3 atopic diseases [aOR = 2.58 (95% CI,
2.43–2.73; P < 0.001)] (Table 2). We also reported full
multivariable logistic regression models of association
between IDA and atopic disease in Additional file 1:
Table S2. In addition, there was no evidence of multicol-
linearity among covariates. Maximum VIF (variance in-
flation factor) was lower than 2.0, and lowest eigenvalue
was 0.32.
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Discussion
In this study, we showed that prevalence of IDA was as-
sociated with three atopic diseases (atopic dermatitis, al-
lergic rhinitis, and asthma) by a large-scale data analysis
of nearly 850,000 South Korean pediatric patients. We
also found that the aOR of IDA was increased in chil-
dren with multiple atopic disease diagnoses. Our results
showed that comorbid medical conditions, the use of
medication, gender, age, and socio-economic level were
associated with the prevalence of IDA.
The prevalence of anemia in pediatric patients was ap-
proximately 3.42% in this study, the majority of which was
IDA (2.31%); this figure is lower than the results of exist-
ing epidemiology studies, which suggest rates between 4
and 6% [12, 13]. The apparently low diagnosis of anemia
in our study may be due to the use of the HIRA-PPS-2016
dataset because, in South Korea, most health screenings
for infants and young children are brief physical examina-
tions and do not routinely involve testing for anemia.
The etiology of anemia varies. AI is an anemia caused
by inflammatory immune activation [14, 15]. AI produces
similar hematological findings to iron deficiency anemia
(IDA), including low hemoglobin and iron levels, and
shows similar clinical manifestation to anemia in patients
with chronic obstructive pulmonary disease, CKD, and
congestive heart failure [16, 17]. We hypothesized that in-
flammatory conditions in patients with atopic diseases
would increase their risk of anemia because previous stud-
ies have shown that inflammation, CKD, cancer, and sys-
temic infection correlate with AI [18–22]. Indeed, in our
study, the association of these diseases and medication
was also high in patients diagnosed with IDA.
Inflammatory disease, malignancy, and infections are the
major medical conditions underlying AI. In addition, com-
bined anemia of IDA and AI is typically presented in pa-
tients with irritable bowel disease (IBD), or gastrointestinal
(GI) malignancy [23]. Inflammatory diseases or depression
would be a confounding factor which impact on both risk
of anemia and atopic disease. Patients with moderate to se-
vere atopic disease were treated by immunosuppressant
such as methotrexate, cyclosporine, or steroids. Those med-
ications could cause bleeding, anemia, or hematologic
Fig. 1 Flow diagram for study subject inclusion
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disorders [24–26]. Therefore, we included those medical
condition and medication as covariates to adjust for minim-
izing their effects on outcome.
Most covariates we included were still associated with
increased prevalence of IDA. Chronic obstructive pulmon-
ary disease (COPD) and methotrexate, however, showed
null effects after adjusting all covariates. As is well known,
COPD is a disease that increases in incidence after middle
age. We only included pediatric patients in this study, so it
may have led to differences in outcomes from other in-
flammatory diseases in the outcome of COPD. Methotrex-
ate is an antimetabolite and antifolate, which leads low
level of folic acid in the body. Hematologic toxicity such
as anemia in the methotrexate users would be more like
folate deficiency anemia not IDA.
Because AI has a hematological manifestation similar
to IDA [27], hepcidin is a useful indicator to differentiate
AI from IDA [28, 29]. Unfortunately, hepcidin is rarely
assessed in common clinical settings. Therefore, patients
with AI may be diagnosed with IDA instead of AI, which
would result in an artificially inflated risk of IDA in
atopic disease patients.
In this study, we found that multiple atopic disease diagno-
ses in a patient had stronger associations with IDA, which is
consistent with previous research [14]. Notably, Drury’s study
showed allergic rhinitis was not associated with anemia. Our
study indicated that the aOR of allergic rhinitis, although sta-
tistically significant, was lower than that for other atopic dis-
eases (asthma and atopic dermatitis). The effect of systemic
inflammation may therefore differ among atopic diseases.
Table 1 Patient characteristics according to iron deficiency anemia
Frequency (%) Crude OR (95% CI) P value
No anemia N = (827,124) IDA
(N = 19,594)
Age 8.97 (5.16)a 5.98 (5.48)a 0.89 (0.89–0.89) <.001
Sex
Male 428,361 (51.79) 9253 (47.22) 1 [Reference]
Female 398,763 (48.21) 10,341 (52.78) 1.20 (1.17–1.24) <.001
Insurance Types
Health insurance 806,892 (97.55) 19,054 (97.24) 1 [Reference]
Medical aid 20,232 (2.45) 540 (2.76) 1.13 (1.04–1.23) 0.006
Systemic infection
Meningitis 1645 (0.20) 130 (0.66) 3.35 (2.80–4.01) <.001
BJI 803 (0.10) 41 (0.21) 2.16 (1.58–2.96) <.001
Sepsis 3071 (0.37) 478 (2.44) 6.71 (6.09–7.40) <.001
HEP 2445 (0.30) 695 (3.55) 12.40 (11.39–13.51) <.001
CKD 57 (0.01) 26 (0.13) 19.28 (12.12–30.67) <.001
Mental disorder
Depression 3931 (0.48) 178 (0.91) 1.92 (1.65–2.23) <.001
Anxiety 6518 (0.79) 309 (1.58) 2.02 (1.80–2.26) <.001
Chronic inflammation
PUD 15,248 (1.84) 640 (3.27) 1.80 (1.66–1.95) <.001
COPD 12,650 (1.53) 422 (2.15) 1.42 (1.29–1.56) <.001
SLE 228 (0.03) 26 (0.13) 4.83 (3.22–7.25) <.001
RA 1454 (0.18) 96 (0.49) 2.80 (2.27–3.44) <.001
IBD 265 (0.03) 68 (0.35) 10.87 (8.32–14.19) <.001
Cancer 1147 (0.14) 133 (0.68) 4.92 (4.11–5.89) <.001
Medication
Steroid 333,265 (40.29) 11,726 (59.84) 2.21 (2.15–2.27) <.001
Methotrexate 162 (0.02) 26 (0.13) 6.78 (4.48–10.27) <.001
Cyclosporine 302 (0.04) 29 (0.15) 4.07 (2.78–5.96) <.001
amean (standard deviation)
IDA Iron deficiency anemia, BJI Bone and joint infection, HEP Hepatitis, CKD Chronic kidney disease, PUD Peptic ulcer disease, COPD Chronic obstructive pulmonary
disease, SLE Systemic lupus erythematosus, RA Rheumatoid arthritis, IBD Irritable bowel disease
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We confirmed that the prevalence of IDA in pediatric
patients with atopic dermatitis, allergic rhinitis, and/or
asthma is higher than in patients without atopic disease.
Because previous research has not provided evidence
that atopic patients are at risk for anemia, monitoring
and treatment guidelines for anemia in pediatric patients
with atopic disease do not exist. However, treatment for
anemia in children is crucial because of its potential to
reduce quality of life [30], increase morbidity [31–34],
and negatively affect school performance and physical
growth [35, 36]. Therefore, we suggest that appropriate
treatment of patients with atopic disease may require as-
sessment for and treatment of IDA or AI.
Our study has several limitations. First, it is a cross-
sectional study, and, thus, we cannot determine a causa-
tive relationship between atopic disease and anemia.
However, the reverse causation—that anemia causes
atopic disease—is unlikely given the pathophysiology of
anemia and atopic disease. Second, because of its simi-
larities to IDA, we have not directly assessed AI, nor
have we identified whether the inflammatory state of
atopic disease causes AI. Third, we cannot completely
rule out selection bias because healthy children are more
likely not to have screening for anemia. However, HIRA
reported that most of the population use medical service
at least once a year. In addition, unlike other serious
health condition or medication use we included as co-
variates, anemia testing is not common in children with
atopic disease, so the impact on outcomes would be lim-
ited. Nevertheless, this study has strengths, such as the
inclusion of medical conditions and medications as co-
variates. We used diagnostic code, not self-report, for
definition of disease. Lastly, by utilizing a large dataset
sampled from national healthcare claims, we were able
to objectively assess the association between atopic dis-
ease and anemia.
Conclusions
We suggest that the inflammatory conditions that
characterize atopic diseases (atopic dermatitis, allergic
rhinitis, and asthma) could associated with IDA and/or
AI. Further study is needed to clarify the distinction be-
tween IDA and AI to better understand the cause of
anemia in patients with inflammatory diseases.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12887-019-1836-5.
Additional file 1: Table S1. The list of KCD-7 diagnostic codes of dis-
eases in the study. Table S2. Adjusted odds ratio of IDA for all covariates
in final model.
Abbreviations
AI: Anemia of inflammation; aOR: Adjusted odds ratio; CI: Confidence
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Table 2 Association between atopic diseases and iron deficiency anemia
Atopic diseases Frequency (%) Crude OR (95%
CI)








No 722,427 (87.34) 14,853 (75.80) 1 [Reference] 1 [Reference]
Yes 104,697 (12.66) 4741 (24.20) 2.20 (2.13–2.28) <.001 1.42 (1.37–1.47) <.001
Allergic rhinitis
No 534,731 (64.65) 10,344 (52.79) 1 [Reference] 1 [Reference]
Yes 292,393 (35.35) 9250 (47.21) 1.64 (1.59–1.68) <.001 1.25 (1.21–1.29) <.001
Asthma
No 600,218 (72.57) 9393 (47.94) 1 [Reference] 1 [Reference]
Yes 226,906 (27.43) 10,201 (52.06) 2.87 (2.79–2.96) <.001 1.71 (1.65–1.76) <.001
Atopic diseases, No.
0 388,310 (46.95) 5170 (26.39) 1 [Reference] 1 [Reference]
1 280,108 (33.87) 6638 (33.88) 1.78 (1.72–1.85) <.001 1.30 (1.25–1.35) <.001
2 132,230 (15.99) 5804 (29.62) 3.30 (3.17–3.42) <.001 1.81 (1.73–1.89) <.001
3 26,476 (3.20) 1982 (10.12) 5.62 (5.33–5.93) <.001 2.58 (2.43–2.73) <.001
IDA Iron deficiency anemia
Adjusted by age, sex, insurance type, meningitis, bone and joint infection, sepsis, hepatitis, depression, anxiety, chronic kidney disease, peptic ulcer disease,
chronic obstructive pulmonary disease, systemic lupus erythematosus, rheumatoid arthritis, irritable bowel disease, cancer, steroid, methotrexate, cyclosporine
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